More than 1000 authenticated secondary sources , such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data
Contraindications Do not use DSIP if you: Are pregnant or breastfeeding (insufficient safety data) Have sleep apnea or other breathing-related sleep disorders (sedation risk) Take prescription sedatives or sleep medications Have a history of severe reactions to injected peptides Are under 18 years old If you have any chronic medical condition or take regular medications, consult a healthcare provider familiar with peptide therapies before starting DSIP
The risk of losing lean mass on GLP-1 therapy Semaglutide can be an effective injectable medication for weight loss when used along with dietary modifications and exercise
NAD+ is a coenzyme naturally present in the human body and is involved in cellular processes related to energy
Statistical analyses Statistical analyses were conducted using SPSS Statistics software (v.28.0